sur VALNEVA (EPA:VLA)
Valneva to Announce First Half 2026 Financial Results
Valneva SE, a company specializing in vaccines, will publish its financial results for the first half of 2026 on August 13. The company plans a live webcast at 3 p.m. CET to discuss these results and offer a business update. The webcast will be accessible on Valneva's official website, with an archived version available post-event.
Valneva focuses on developing vaccines for infectious diseases with unmet medical needs. Their pipeline includes partnerships for significant vaccine candidates, such as the Lyme disease vaccine with Pfizer. Other advanced developments include vaccines targeting Shigella and various global health threats.
The announcement contains forward-looking statements about Valneva's business development and market approvals, emphasizing underlying uncertainties. These factors could affect the company’s future performance and results, despite current expectations.
R. P.
Copyright © 2026 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de VALNEVA